Why the study?
What is the persistence rate of secondary prevention medications 3 months after acute ischemic stroke or TIA?
What is the persistence rate of secondary prevention medications 3 months after acute ischemic stroke or TIA?
A significant proportion (almost one-third) of AIS/TIA patients in China discontinue secondary prevention medications within 3 months of discharge, highlighting a need for interventions to improve adherence.
Supports targeted adherence interventions after AIS/TIA; leaves open which strategies best sustain persistence.
Almost one-third of patients of AIS/TIA had stopped one or more secondary prevention medications by 3-month postdischarge. Further studies on identifying potential barriers and means to improve persistent use of secondary prevention interventions are needed.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: